Insider acquisitions
Explore purchases, stock awards, gifts, exercises, and conversions. These records cover acquisitions only; sales are not included.
Transaction timeline & trade size
Choose a reporting owner, transaction period, and security. Open any point for the filing.
Apr 14, 2025 – Oct 27, 2025 · Transaction dates · Current page sample
Reported transaction sizes · security units
RETRACTABLE TECHNOLOGIES INC · Common Stock · Purchase (code P) · Non-derivative · Not reported
Swipe the chart to see the full date range. Exact records are available in the table below.
1 transaction plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.
50 dated transactions in this page sample · 44 reporting owners.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type | Quantity | Price | Reference value | Currency |
|---|---|---|---|---|---|---|---|
| Oct 24, 2025 | Pasithea Therapeutics Corp.Stock Option (right to buy) | Dumesnil Simon (Director) | Stock award | 42,913 | 0 | 0 | Not reported |
| Oct 21, 2025 | Triller Group Inc.Common Stock | Shu Pei Huang Desmond (Acting Group CFO) | Stock award | 2,000,000 | Not reported | Not reported | Not reported |
| Oct 21, 2025 | Triller Group Inc.Common Stock | Ng Wing Fai (Chief Executive Officer · Director) | Stock award | 4,000,000 | Not reported | Not reported | Not reported |
| Oct 21, 2025 | Triller Group Inc.Common Stock | Wong Yun Pun Felix (Director) | Stock award | 500,000 | Not reported | Not reported | Not reported |
| Oct 21, 2025 | Triller Group Inc.Common Stock | Ng Thomas Kwok On (Director) | Stock award | 500,000 | Not reported | Not reported | Not reported |
| Oct 21, 2025 | Triller Group Inc.Common Stock | CHAN BRIAN CHUNG YAU (Director) | Stock award | 500,000 | Not reported | Not reported | Not reported |
| Oct 23, 2025 | USANA HEALTH SCIENCES INCCommon Stock | FULLER GILBERT A (Director) | Exercise / conversion | 1,057 | Not reported | Not reported | Not reported |
| Oct 24, 2025 | ACUITY INC. (DE)Common Stock | ASHE NEIL (President & CEO · Director) | Stock award | 43,474 | 0 | 0 | Not reported |
| Oct 23, 2025 | ACUITY INC. (DE)Common Stock | ASHE NEIL (President & CEO · Director) | Stock award | 6,751 | 0 | 0 | Not reported |
| Oct 23, 2025 | Q32 Bio Inc.Stock Option (Right to Buy) | Lundberg Sven Ante (Director) | Stock award | 53,521 | 0 | 0 | Not reported |
| Oct 23, 2025 | Q32 Bio Inc.Stock Option (Right to Buy) | Iwicki Mark T (Director) | Stock award | 53,521 | 0 | 0 | Not reported |
| Oct 23, 2025 | Q32 Bio Inc.Stock Option (Right to Buy) | Manke Isaac (Director) | Stock award | 53,521 | 0 | 0 | Not reported |
| Oct 23, 2025 | Q32 Bio Inc.Stock Option (Right to Buy) | Xu Diyong (Director) | Stock award | 53,521 | 0 | 0 | Not reported |
| Oct 23, 2025 | Q32 Bio Inc.Stock Option (Right to Buy) | Thistle Mary (Director) | Stock award | 53,521 | 0 | 0 | Not reported |
| Oct 23, 2025 | Q32 Bio Inc.Stock Option (Right to Buy) | GRAYZEL DAVID S. (Director) | Stock award | 53,521 | 0 | 0 | Not reported |
| Oct 23, 2025 | Q32 Bio Inc.Stock Option (Right to Buy) | TZIANABOS ARTHUR (Director) | Stock award | 53,521 | 0 | 0 | Not reported |
| Oct 23, 2025 | Q32 Bio Inc.Stock Option (Right to Buy) | LAPORTE KATHLEEN (Director) | Stock award | 53,521 | 0 | 0 | Not reported |
| Oct 24, 2025 | 4D Molecular Therapeutics, Inc.Common Stock | Bizily Scott (Chief Legal Officer) | Exercise / conversion | 1,084 | 6.49 | 7,035.16 | Not reported |
| Oct 24, 2025 | Hub Group, Inc.Class A Common Stock | Mathews Dennis P. (Chief Accounting Officer) | Stock award | 2,808 | 0 | 0 | Not reported |
| Oct 27, 2025 | Corbus Pharmaceuticals Holdings, Inc.Common Stock, par value $0.0001 per share | Cohen Yuval (Chief Executive Officer · Director) | Exercise / conversion | 8,973 | 4.26 | 38,224.98 | Not reported |
| Oct 24, 2025 | Corbus Pharmaceuticals Holdings, Inc.Common Stock, par value $0.0001 per share | Cohen Yuval (Chief Executive Officer · Director) | Exercise / conversion | 18,660 | 4.26 | 79,491.6 | Not reported |
| Oct 24, 2025 | Corbus Pharmaceuticals Holdings, Inc.Common Stock, par value $0.0001 per share | Moran Sean F. (Chief Financial Officer) | Exercise / conversion | 12,981 | 4.26 | 55,299.06 | Not reported |
| Oct 24, 2025 | HEXCEL CORP /DE/Common Stock | Merlot Thierry (See Remarks) | Exercise / conversion | 2,490 | 0 | 0 | Not reported |
| Oct 23, 2025 | NEW YORK TIMES COClass A Common Stock | MCANDREWS BRIAN P (Director) | Stock award | 164 | 0 | 0 | Not reported |
| Oct 23, 2025 | RETRACTABLE TECHNOLOGIES INCCommon Stock | SHAW THOMAS J (PRESIDENT AND CEO · Director · 10% owner) | Purchase | 356 | 0.951 | 338.556 | Not reported |
| Oct 23, 2025 | BRC Inc.Class A Common Stock | Kadenacy Stephen M (Director) | Stock award | 124,113 | 0 | 0 | Not reported |
| Oct 25, 2025 | CULLEN/FROST BANKERS, INC.Common Stock, $0.01 par value | GREEN PHILLIP D (Chairman and CEO · Director) | Exercise / conversion | 11,097 | 0 | 0 | Not reported |
| Oct 23, 2025 | VICOR CORPCommon Stock | EICHTEN ESTIA J (Director) | Exercise / conversion | 4,713 | 10.61 | 50,004.93 | Not reported |
| Oct 24, 2025 | Salesforce, Inc.Common Stock | Benioff Marc (Chair and CEO · Director) | Exercise / conversion | 2,250 | 161.5 | 363,375 | Not reported |
| Oct 24, 2025 | UNITED THERAPEUTICS CorpCommon Stock | ROTHBLATT MARTINE A (Chairperson & CEO · Director) | Exercise / conversion | 4,000 | 120.26 | 481,040 | Not reported |
| Oct 23, 2025 | UNITED THERAPEUTICS CorpCommon Stock | ROTHBLATT MARTINE A (Chairperson & CEO · Director) | Exercise / conversion | 4,000 | 120.26 | 481,040 | Not reported |
| Oct 23, 2025 | Viridian Therapeutics, Inc.\DECommon Stock | Fairmount Healthcare Fund II L.P. (Director · 10% owner) · Fairmount Funds Management LLC (Director · 10% owner) · Fairmount Healthcare Fund II GP LLC (Director · 10% owner) | Purchase | 454,545 | 22 | 9,999,990 | Not reported |
| Oct 20, 2025 | DeFi Capital Markets, Inc.Stock Options (Right to Buy) | Huff James Ballard (Chief Financial Officer) | Stock award | 25,000 | 0 | 0 | Not reported |
| Oct 24, 2025 | AMPHENOL CORP /DE/Class A Common Stock | WALTER LUC (President, HES Division) | Exercise / conversion | 152,318 | 43.25 | 6,587,753.5 | Not reported |
| Oct 24, 2025 | AMPHENOL CORP /DE/Class A Common Stock | WALTER LUC (President, HES Division) | Exercise / conversion | 212,800 | 33.295 | 7,085,176 | Not reported |
| Oct 24, 2025 | CATERPILLAR INCPhantom Stock Units | Creed Joseph E (Chief Executive Officer) | Stock award | 29 | 522.73 | 15,159.17 | Not reported |
| Oct 24, 2025 | CATERPILLAR INCPhantom Stock Units | Kaiser Jason (Group President) | Stock award | 14 | 522.73 | 7,318.22 | Not reported |
| Oct 24, 2025 | CATERPILLAR INCPhantom Stock Units | Johnson Denise C (Group President) | Stock award | 19 | 522.73 | 9,931.87 | Not reported |
| Oct 27, 2025 | Quest Resource Holding CorpCommon Stock, $0.001 par value per share | KITT BARRY M (10% owner) | Purchase | 62,867 | 1.3607 | 85,543.1269 | Not reported |
| Oct 24, 2025 | Quest Resource Holding CorpCommon Stock, $0.001 par value per share | KITT BARRY M (10% owner) | Purchase | 33,480 | 1.3286 | 44,481.528 | Not reported |
| Oct 23, 2025 | Quest Resource Holding CorpCommon Stock, $0.001 par value per share | KITT BARRY M (10% owner) | Purchase | 103,412 | 1.2626 | 130,567.9912 | Not reported |
| Oct 27, 2025 | CYTOKINETICS INCCommon Stock | WIERENGA WENDELL (Director) | Exercise / conversion | 4,375 | 10 | 43,750 | Not reported |
| Oct 23, 2025 | Rani Therapeutics Holdings, Inc.Warrant to Purchase Class A Common Stock | IMRAN MIR A (Director · 10% owner) | Purchase | 2,083,334 | 0 | 0 | Not reported |
| Oct 23, 2025 | Rani Therapeutics Holdings, Inc.Class A Common Stock | IMRAN MIR A (Director · 10% owner) | Purchase | 2,083,334 | 0.605 | 1,260,417.07 | Not reported |
| Oct 23, 2025 | NEW YORK TIMES COClass A Common Stock | ROGERS JOHN W JR (Director) | Stock award | 96 | 0 | 0 | Not reported |
| Oct 23, 2025 | ZeroStack Corp.Convertible Promissory Note | Heinrich Michael (Executive Chairman · Director) | Other acquisition | 4,902,220 | Not reported | Not reported | Not reported |
| Oct 23, 2025 | USANA HEALTH SCIENCES INCCommon Stock | Pelosi Peggie (Director) | Exercise / conversion | 1,057 | Not reported | Not reported | Not reported |
| Oct 24, 2025 | FTI CONSULTING, INCCommon Stock | Gunby Steven Henry (CEO, Chairman and President · Director) | Purchase | 7,500 | 151.12 | 1,133,400 | Not reported |
| May 7, 2025 | EOG RESOURCES INCCommon Stock | Leitzell Jeffrey R. (EVP & COO) | Purchase | 4 | 107.97 | 431.88 | Not reported |
| Apr 14, 2025 | EOG RESOURCES INCCommon Stock | Leitzell Jeffrey R. (EVP & COO) | Purchase | 3 | 107.64 | 322.92 | Not reported |
Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transaction details
Reporting owners, quantities, prices, and source filings.
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Transacted: | Pasithea Therapeutics Corp.KTTA · company listings | Dumesnil SimonDirector | Stock awardStock Option (right to buy)Derivative security · Code A | 42,913 | 0Value: 0Not reported | View ↗ |
| Transacted: | Triller Group Inc.No current listing · company listings | Shu Pei Huang DesmondActing Group CFO | Stock awardCommon StockNon-derivative security · Code A | 2,000,000 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | Triller Group Inc.No current listing · company listings | Ng Wing FaiChief Executive Officer · Director | Stock awardCommon StockNon-derivative security · Code A | 4,000,000 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | Triller Group Inc.No current listing · company listings | Wong Yun Pun FelixDirector | Stock awardCommon StockNon-derivative security · Code A | 500,000 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | Triller Group Inc.No current listing · company listings | Ng Thomas Kwok OnDirector | Stock awardCommon StockNon-derivative security · Code A | 500,000 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | Triller Group Inc.No current listing · company listings | CHAN BRIAN CHUNG YAUDirector | Stock awardCommon StockNon-derivative security · Code A | 500,000 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | USANA HEALTH SCIENCES INCUSNA · company listings | FULLER GILBERT ADirector | Exercise / conversionCommon StockNon-derivative security · Code M | 1,057 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | ACUITY INC. (DE)AYI · company listings | ASHE NEILPresident & CEO · Director | Stock awardCommon StockNon-derivative security · Code A | 43,474 | 0Value: 0Not reported | View ↗ |
| Transacted: | ACUITY INC. (DE)AYI · company listings | ASHE NEILPresident & CEO · Director | Stock awardCommon StockNon-derivative security · Code A | 6,751 | 0Value: 0Not reported | View ↗ |
| Transacted: | Q32 Bio Inc.QTTB · company listings | Lundberg Sven AnteDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 53,521 | 0Value: 0Not reported | View ↗ |
| Transacted: | Q32 Bio Inc.QTTB · company listings | Iwicki Mark TDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 53,521 | 0Value: 0Not reported | View ↗ |
| Transacted: | Q32 Bio Inc.QTTB · company listings | Manke IsaacDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 53,521 | 0Value: 0Not reported | View ↗ |
| Transacted: | Q32 Bio Inc.QTTB · company listings | Xu DiyongDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 53,521 | 0Value: 0Not reported | View ↗ |
| Transacted: | Q32 Bio Inc.QTTB · company listings | Thistle MaryDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 53,521 | 0Value: 0Not reported | View ↗ |
| Transacted: | Q32 Bio Inc.QTTB · company listings | GRAYZEL DAVID S.Director | Stock awardStock Option (Right to Buy)Derivative security · Code A | 53,521 | 0Value: 0Not reported | View ↗ |
| Transacted: | Q32 Bio Inc.QTTB · company listings | TZIANABOS ARTHURDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 53,521 | 0Value: 0Not reported | View ↗ |
| Transacted: | Q32 Bio Inc.QTTB · company listings | LAPORTE KATHLEENDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 53,521 | 0Value: 0Not reported | View ↗ |
| Transacted: | 4D Molecular Therapeutics, Inc.FDMT · company listings | Bizily ScottChief Legal Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 1,084 | 6.49Value: 7,035.16Not reported | View ↗ |
| Transacted: | Hub Group, Inc.HUBG · company listings | Mathews Dennis P.Chief Accounting Officer | Stock awardClass A Common StockNon-derivative security · Code A | 2,808 | 0Value: 0Not reported | View ↗ |
| Transacted: | Corbus Pharmaceuticals Holdings, Inc.CRBP · company listings | Cohen YuvalChief Executive Officer · Director | Exercise / conversionCommon Stock, par value $0.0001 per shareNon-derivative security · Code M | 8,973 | 4.26Value: 38,224.98Not reported | View ↗ |
| Transacted: | Corbus Pharmaceuticals Holdings, Inc.CRBP · company listings | Cohen YuvalChief Executive Officer · Director | Exercise / conversionCommon Stock, par value $0.0001 per shareNon-derivative security · Code M | 18,660 | 4.26Value: 79,491.6Not reported | View ↗ |
| Transacted: | Corbus Pharmaceuticals Holdings, Inc.CRBP · company listings | Moran Sean F.Chief Financial Officer | Exercise / conversionCommon Stock, par value $0.0001 per shareNon-derivative security · Code M | 12,981 | 4.26Value: 55,299.06Not reported | View ↗ |
| Transacted: | HEXCEL CORP /DE/HXL · company listings | Merlot ThierrySee Remarks | Exercise / conversionCommon StockNon-derivative security · Code M | 2,490 | 0Value: 0Not reported | View ↗ |
| Transacted: | NEW YORK TIMES CONYT · company listings | MCANDREWS BRIAN PDirector | Stock awardClass A Common StockNon-derivative security · Code A | 164 | 0Value: 0Not reported | View ↗ |
| Transacted: | RETRACTABLE TECHNOLOGIES INCRVP · company listings | SHAW THOMAS JPRESIDENT AND CEO · Director · 10% owner | PurchaseCommon StockNon-derivative security · Code P | 356 | 0.951 *Value: 338.556Not reported | View ↗ |
| Transacted: | BRC Inc.BRCC · company listings | Kadenacy Stephen MDirector | Stock awardClass A Common StockNon-derivative security · Code A | 124,113 | 0Value: 0Not reported | View ↗ |
| Transacted: | CULLEN/FROST BANKERS, INC.No current listing · company listings | GREEN PHILLIP DChairman and CEO · Director | Exercise / conversionCommon Stock, $0.01 par valueNon-derivative security · Code M | 11,097 | 0Value: 0Not reported | View ↗ |
| Transacted: | VICOR CORPVICR · company listings | EICHTEN ESTIA JDirector | Exercise / conversionCommon StockNon-derivative security · Code M | 4,713 | 10.61Value: 50,004.93Not reported | View ↗ |
| Transacted: | Salesforce, Inc.CRM · company listings | Benioff MarcChair and CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 2,250 | 161.5Value: 363,375Not reported | View ↗ |
| Transacted: | UNITED THERAPEUTICS CorpUTHR · company listings | ROTHBLATT MARTINE AChairperson & CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 4,000 | 120.26Value: 481,040Not reported | View ↗ |
| Transacted: | UNITED THERAPEUTICS CorpUTHR · company listings | ROTHBLATT MARTINE AChairperson & CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 4,000 | 120.26Value: 481,040Not reported | View ↗ |
| Transacted: | Viridian Therapeutics, Inc.\DEVRDN · company listings | Fairmount Healthcare Fund II L.P.Director · 10% owner Fairmount Funds Management LLCDirector · 10% owner Fairmount Healthcare Fund II GP LLCDirector · 10% owner Joint filing · amounts unallocated | PurchaseCommon StockNon-derivative security · Code P | 454,545 | 22Value: 9,999,990Not reported | View ↗ |
| Transacted: | DeFi Capital Markets, Inc.DCM · company listings | Huff James BallardChief Financial Officer | Stock awardStock Options (Right to Buy)Derivative security · Code A | 25,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | AMPHENOL CORP /DE/APH · company listings | WALTER LUCPresident, HES Division | Exercise / conversionClass A Common StockNon-derivative security · Code M | 152,318 | 43.25Value: 6,587,753.5Not reported | View ↗ |
| Transacted: | AMPHENOL CORP /DE/APH · company listings | WALTER LUCPresident, HES Division | Exercise / conversionClass A Common StockNon-derivative security · Code M | 212,800 | 33.295Value: 7,085,176Not reported | View ↗ |
| Transacted: | CATERPILLAR INCCAT · company listings | Creed Joseph EChief Executive Officer | Stock awardPhantom Stock UnitsDerivative security · Code A | 29 | 522.73Value: 15,159.17Not reported | View ↗ |
| Transacted: | CATERPILLAR INCCAT · company listings | Kaiser JasonGroup President | Stock awardPhantom Stock UnitsDerivative security · Code A | 14 | 522.73Value: 7,318.22Not reported | View ↗ |
| Transacted: | CATERPILLAR INCCAT · company listings | Johnson Denise CGroup President | Stock awardPhantom Stock UnitsDerivative security · Code A | 19 | 522.73Value: 9,931.87Not reported | View ↗ |
| Transacted: | Quest Resource Holding CorpQRHC · company listings | KITT BARRY M10% owner | PurchaseCommon Stock, $0.001 par value per shareNon-derivative security · Code P | 62,867 | 1.3607Value: 85,543.1269Not reported | View ↗ |
| Transacted: | Quest Resource Holding CorpQRHC · company listings | KITT BARRY M10% owner | PurchaseCommon Stock, $0.001 par value per shareNon-derivative security · Code P | 33,480 | 1.3286Value: 44,481.528Not reported | View ↗ |
| Transacted: | Quest Resource Holding CorpQRHC · company listings | KITT BARRY M10% owner | PurchaseCommon Stock, $0.001 par value per shareNon-derivative security · Code P | 103,412 | 1.2626Value: 130,567.9912Not reported | View ↗ |
| Transacted: | CYTOKINETICS INCCYTK · company listings | WIERENGA WENDELLDirector | Exercise / conversionCommon StockNon-derivative security · Code M | 4,375 | 10Value: 43,750Not reported | View ↗ |
| Transacted: | Rani Therapeutics Holdings, Inc.RANI · company listings | IMRAN MIR ADirector · 10% owner | PurchaseWarrant to Purchase Class A Common StockDerivative security · Code P | 2,083,334 | 0Value: 0Not reported | View ↗ |
| Transacted: | Rani Therapeutics Holdings, Inc.RANI · company listings | IMRAN MIR ADirector · 10% owner | PurchaseClass A Common StockNon-derivative security · Code P | 2,083,334 | 0.605Value: 1,260,417.07Not reported | View ↗ |
| Transacted: | NEW YORK TIMES CONYT · company listings | ROGERS JOHN W JRDirector | Stock awardClass A Common StockNon-derivative security · Code A | 96 | 0Value: 0Not reported | View ↗ |
| Transacted: | ZeroStack Corp.ZSTK · company listings | Heinrich MichaelExecutive Chairman · Director | Other acquisitionConvertible Promissory NoteDerivative security · Code X | 4,902,220 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | USANA HEALTH SCIENCES INCUSNA · company listings | Pelosi PeggieDirector | Exercise / conversionCommon StockNon-derivative security · Code M | 1,057 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | FTI CONSULTING, INCFCN · company listings | Gunby Steven HenryCEO, Chairman and President · Director | PurchaseCommon StockNon-derivative security · Code P | 7,500 | 151.12Value: 1,133,400Not reported | View ↗ |
| Transacted: | EOG RESOURCES INCEOG · company listings | Leitzell Jeffrey R.EVP & COO | PurchaseCommon StockNon-derivative security · Code P | 4 | 107.97Value: 431.88Not reported | View ↗ |
| Transacted: | EOG RESOURCES INCEOG · company listings | Leitzell Jeffrey R.EVP & COO | PurchaseCommon StockNon-derivative security · Code P | 3 | 107.64Value: 322.92Not reported | View ↗ |
50 transactions on this page. Filing date, newest first.
Filters use the date a filing was submitted, not the date of the transaction. Coverage is incomplete while historical records are being loaded. How we organize the data →